FDA — authorised 14 January 1986
- Application: ANDA088389
- Marketing authorisation holder: DEPROCO
- Local brand name: LIGNOSPAN FORTE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Lignospan Forte in United States
FDA authorised Lignospan Forte on 14 January 1986
Marketing authorisations
FDA
- Status: approved
Lignospan Forte in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Lignospan Forte approved in United States?
Yes. FDA authorised it on 14 January 1986; FDA has authorised it.
Who is the marketing authorisation holder for Lignospan Forte in United States?
DEPROCO holds the US marketing authorisation.